Sort
39,280 grants matching “leukemia”
Chromosome Architecture and Domains of Repression
$478,751Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2003 · GM
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
$478,652Mingyi Xie · University Of Florida · R01 · FY2024 · CA
Mechanism of Therapy in high-risk AML
$478,645Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Mechanism of Therapy in high-risk AML
$478,645Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA
Training Program in Molecular Hematology
$478,570Grover Carlton Bagby · Oregon Health & Science University · T32 · FY2011 · HL
ABERRANT SIGNALING IN ACUTE MYELOID LEUKEMIA
$478,557Alex Kentsis · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Health Promotion in Minority Childhood Cancer Survivors
$478,477Melinda R Stolley · University Of Illinois At Chicago · R01 · FY2010 · CA
Southern Oncology Network on Adverse Reactions (SONAR) - Focus on Tyrosine Kinase
$478,426Richard Michael Schulz · University Of South Carolina At Columbia · R01 · FY2012 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$478,386University Of Rochester · U10 · FY2000 · CA
Clinical Investigation of Epigenetic Therapy
$478,381John C Byrd · Ohio State University · P01 · FY2007 · CA
Pre-BCR Function Selecting Novel B Cell Receptors in Chronic Lymphocytic Leukemia
$478,343Richard R Hardy · Research Inst Of Fox Chase Can Ctr · RC1 · FY2009 · CA
Regulation of Normal and Pathogenic B Cell Proliferation by a c-Myc-initiated Transcription Factor Cascade
$478,281Takeshi Egawa · Washington University · R01 · FY2020 · AI
INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES
$478,215John C Byrd · Ohio State University · P01 · FY2008 · CA
Occupational and Environmental Determinants of Cancer among Women and Minorities
$478,179Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Characterization of SLE-susceptibility loci on mouse chromosome 1
$478,127Laurence Morel · University Of Florida · R01 · FY2015 · AI
Characterization of SLE-susceptibility loci on mouse chromosome 1
$478,127Laurence Morel · University Of Florida · R01 · FY2016 · AI
Characterization of SLE-susceptibility loci on mouse chromosome 1
$478,127Laurence Morel · University Of Florida · R01 · FY2017 · AI
Developing a novel therapeutic strategy for overcoming TKI resistance in ALL
$478,090Shaoguang Li · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Inflammation, Macrophage Differentiation, and Cancer
$478,079Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Safe, Silencing-Resistant, Non-Oncogenic Globin Expression Cassettes
$477,970Eric E Bouhassira · Albert Einstein College Of Medicine · R01 · FY2008 · HL
Targeting altered phosphatase-dependent signaling to overcome the inefficacy of targeted therapy in myeloproliferative neoplasms
$477,968Gary W Reuther · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · HL
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$477,962Stephen S Hecht · University Of Minnesota · R37 · FY2008 · CA
Transcriptional regulatory landscapes underlying FEZ Formation
$477,953Ralph S Marcucio · University Of California, San Francisco · R01 · FY2023 · DE
Administrative Core
$477,862Sumithra Jay Mandrekar · Mayo Clinic Rochester · U10 · FY2024 · CA
Microchimerism as AlloImmunity
$477,844J. Lee Lee Nelson · Fred Hutchinson Cancer Research Center · R01 · FY2016 · HL